Product information and disease descriptionProduct descriptionProduct informationPharmacology
Mechanism of action
4 evidence topics · 4 sources
Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
Product information and disease descriptionProduct descriptionProduct informationPharmacology
4 evidence topics · 4 sources